Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis.

DiGiovanna JJ, Blank H.

Arch Dermatol. 1984 Jan;120(1):48-51.

PMID:
6419679
2.

Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.

Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A.

Dermatologica. 1987;175(4):183-90.

PMID:
3115841
3.

Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study.

Milman N, Scheibel J, Jessen O.

Acta Derm Venereol. 1980;60(1):85-7.

PMID:
6153847
4.

Failure of lysine in frequently recurrent herpes simplex infection.

Simon CA, Van Melle GD, Ramelet AA.

Arch Dermatol. 1985 Feb;121(2):167-8. No abstract available.

PMID:
3919651
5.

Subjective response to lysine in the therapy of herpes simplex.

Walsh DE, Griffith RS, Behforooz A.

J Antimicrob Chemother. 1983 Nov;12(5):489-96.

PMID:
6423612
6.

Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis.

Thein DJ, Hurt WC.

Oral Surg Oral Med Oral Pathol. 1984 Dec;58(6):659-66.

PMID:
6438572
7.

Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.

Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL.

Ann Intern Med. 1993 Feb 15;118(4):268-72.

PMID:
8380540
9.

[Oral acyclovir therapy in recurrent herpes simplex].

Djawari D.

Z Hautkr. 1986 Nov 15;61(22):1629-32, 1637. German.

PMID:
3811459
10.

Levamisole in patients with recurrent herpes infection.

Jose DG, Minty CC.

Med J Aust. 1980 Oct 4;2(7):390-4.

PMID:
7005629
11.

Management of mucocutaneous herpes simplex virus infections.

Straus SE, Seidlin M, Takiff H.

Drugs. 1984 Apr;27(4):364-72.

PMID:
6723549
12.

Treatment of mucocutaneous presentations of herpes simplex virus infections.

Nikkels AF, Pièrard GE.

Am J Clin Dermatol. 2002;3(7):475-87. Review.

PMID:
12180895
13.

Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.

Busch R, Graubaum HJ, Gruenwald J, Faergemann J.

Adv Ther. 2009 Jul;26(7):719-27. doi: 10.1007/s12325-009-0049-y. Epub 2009 Jul 27.

PMID:
19649583
14.

[Lysine prevention in recurrent labial herpes simplex].

Milman N, Scheibel J, Jessen O.

Ugeskr Laeger. 1980 May 5;142(19):1202-3. Danish. No abstract available.

PMID:
6773197
15.

A multicentered study of lysine therapy in Herpes simplex infection.

Griffith RS, Norins AL, Kagan C.

Dermatologica. 1978;156(5):257-67.

PMID:
640102
16.

Oral acyclovir for the prevention of herpes-associated erythema multiforme.

Lemak MA, Duvic M, Bean SF.

J Am Acad Dermatol. 1986 Jul;15(1):50-4.

PMID:
3722509
17.

[Lysine therapy of recurrent herpes simplex labialis].

Milman N, Jessen O, Scheibel J.

Ugeskr Laeger. 1979 Oct 22;141(43):2960-2. Danish. No abstract available.

PMID:
392853
18.

Treatment of recurrent herpes simplex labialis with levamisole.

Spruance SL, Krueger GG, MacCalman J, Overall JC Jr, Klauber MR.

Antimicrob Agents Chemother. 1979 May;15(5):662-5.

19.

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.

Corey L, Benedetti JK, Critchlow CW, Remington MR, Winter CA, Fahnlander AL, Smith K, Salter DL, Keeney RE, Davis LG, Hintz MA, Connor JD, Holmes KK.

Am J Med. 1982 Jul 20;73(1A):326-34.

PMID:
7048919
20.

An update on short-course intermittent and prevention therapies for herpes labialis.

Gilbert S, Corey L, Cunningham A, Malkin JE, Stanberry L, Whitley R, Spruance S.

Herpes. 2007 Jun;14 Suppl 1:13A-18A. Review.

PMID:
17877887

Supplemental Content

Support Center